Clinical Trials Logo

Clinical Trial Summary

Single shot caudal epidural block is one of the most widespread technique for pediatric pain management after infraumbilical surgical procedures.

However, in a significant proportion of patients, despite good initial analgesia from a caudal block with local anesthetic, pain develops after the block resolves.

In order to decrease postoperative analgesic requirements after caudal block, various drugs such as opioids, ketamine, clonidine, or dexmedetomidine to local anesthetics has been investigated. However, their use has been limited by adverse effects in children.

Recently, many study suggested that epidurally administered dexamethasone could reduce the incidence and severity of postoperative pain in adults. But there is no study concerning the use of dexamethasone, as an adjuvant agent for the caudal epidural block in children.

The investigators performed prospective randomized double-blind study to examine the analgesic effect of dexamethasone added to ropivacaine and ropivacaine alone in caudal analgesia on postoperative pain control in pediatric patients undergoing orchiopexy.

80 children (aged 0.5-5 yr) undergoing day-case orchiopexy were included in this prospective, randomized, double-blinded study. After inhalation induction of general anesthesia, caudal block was applied. Patients were randomly assigned in two groups. Normal saline 0.02mL/Kg added to ropivacaine 0.15% 1.5ml/kg was administered to Group R , dexamethasone 0.1mg/kg added to ropivacaine 0.15% 1.5ml/kg to Group DR. Postoperative pain was recorded at 30min and 1,2,3 h by using Hospital of Eastern Ontario Pain Scale (CHEOPS, 0-10) and Faces Legs Activity Cry Consolability tool (FLACC, 0-10). Participants will be followed for the duration of hospital stay, an expected average of 3 hours.

After discharge, rescue analgesic consumption, pain scores, and adverse effects were evaluated for 24h.

The time to first supplemental oral analgesic medication demand was defined as the time from the end of surgery to the first registration of a VAS ( 0-10) ≥ 5 by parent's observation. Twenty-four hours after surgery, reports of delayed side effects and demands for rescue analgesics from the child were gathered from parents via a telephone interview.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01604915
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase N/A
Start date May 2012
Completion date February 2013

See also
  Status Clinical Trial Phase
Completed NCT02249637 - A Novel Technique of Circumcision Incision Orchidopexy N/A
Completed NCT01701778 - Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children Phase 2
Completed NCT03677453 - Interactive Perioperative Teaching Platform (IPTP) N/A
Completed NCT02110745 - The Effect of Induction Technique on Postoperative Pain and Agitation Phase 4
Completed NCT00435383 - Comparing Oxygen Saturation in Post Anesthesia Care Unit After Different Methods of Pain Relief Phase 2
Completed NCT01896076 - The Caudal Space in Children: Ultrasound Evaluation N/A
Completed NCT00565513 - Cryptorchidism: Impact of in Utero Exposure to Xenobiotics With Hormonal Action N/A
Recruiting NCT04342026 - Role of the Environment and Endocrine Disruptors in Child Cryptorchidism
Recruiting NCT02936024 - One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy (GSLO) N/A